You may have heard one of the many slogans public health officials have adopted as rallying cries during the COVID-19 pandemic: “Stop the Spread”, “Mask
Dr. Mira Behnam of the Institute of Pharmacy and Molecular Biotechnology in Germany has had promising findings that the main protease (Mpro) of SARS-CoV and
Treatment of Covid at early stages of infection could reduce the risk of life-threatening disease progression, but scientists are still struggling to identify and validate
There is increasing evidence for and concerns regarding the neurological impacts of COVID. However, new research may have revealed the risk factors associated with a
Researchers developed a method to identify amino acids important for the entry of viruses such as SARS-CoV-2 into human cells. They analyzed the Spike/ACE2 protein
Recently, a new COVID-19 variant was discovered in the United Kingdom that spreads more quickly and efficiently than other virus strains. A team of German
Since the beginning of the COVID-19 pandemic, researchers have developed over 64 clinical vaccine candidates. Some of the current leading candidates are mRNA vaccines, which
Graphic by Tai Michaels. As the pandemic continues to worsen in many areas, there are worrying signs that the Affordable Care Act, the central law
Graphic by Tai Michaels. The debate between the importance of personalized medicine compared to general medicine is a growing one. As gene sequencing becomes increasingly
Graphic by Ishani Singh. The push for decarceration has become increasingly urgent over the past months as calls for an overhaul of the criminal justice
Graphic by Ishani Singh. According to a recent study conducted by researchers at the University of Maryland School of Medicine, daily use of low-dose aspirin
Three individuals aged 35, 45, and 58 years recently developed Parkinson symptoms following COVID-19 infection, indicating that COVID-19 might increase risk of Parkinson’s disease (PD).